Gemeprost
Gemeprost is a synthetic prostaglandin. Gemeprost is used to to prepare the uterus for surgical termination of pregnancy.
Primary Characteristics
It is of Synthetic origin and belongs to Oxocyclopentylheptenoate.
It belongs to PGF-II alpha-agonist pharmacological group on the basis of mechanism of action and also classified in Abortifacients pharmacological group.
Molecular Weight: 394 · Solubility in Water: Insoluble · Solubility in Alcohol: freely soluble · Non-proprietary name: Gemeprost.

Pharmacokinetics
Elimination: it is metabolised via rapid, plasma half-life is 10-15 mins, renal excretion is 33%.
Advertisement
Indications
Gemeprost is primarily indicated in conditions like Abortion, Second trimester abortion, Second trimester intra-uterine death, Transcervical operative procedures in first trimester.
Contraindications
Gemeprost is contraindicated in conditions like Asthma, Bronchospasm.
Dosage
Gemeprost's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 1 mg | 1 mg | Every 8h | ||
| 0.014 mg/kg | 0.014 mg/kg | — | Intra Vaginal | As Required, prior to surgery |
| Paediatric Dosage (20kg) | ||||
| 0 – 0 | — | — | — | Not Recommended in this Age Group |
| Neonatal Dosage (3kg) | ||||
| 0 – 0 | — | — | Not recommended in this age group | |
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Gemeprost produces potentially life-threatening effects which include Myocardial infarction, Severe hypertension, Coronary artery spasm. Careful monitoring is needed with proper medical management.
Gemeprost is known to cause more or less tolerable side effects which are usually transient. These include Abdominal pain, Constipation , Diarrhea, Dyspepsia , Eczema, Fatigue, GI symptoms, Mild uterine pain, Rashes , Vaginal bleeding.
Warnings / Precautions
Interference in Pathology
Gemeprost may interfere in the diagnosis of No significant effect were recorded on Alkaline Phosphate or on hemosfatic system..
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.22.1.1 — Oxytocics